KRI-1314

Overview

KRI-1314 is an orally active human renin inhibitor with selectivity for primate renin over non-primate renin . KRI-1314 competitively inhibits the binding of recombinant human renin to its substrate, reduces plasma renin activity, lowers blood pressure, and exhibits high stability in tissue homogenates. KRI-1314 is applicable to research on renin-dependent hypertension and hypertension-related studies.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Renin

Product Information

• Catalog No.: HY-183978
• CAS No.: 128053-53-2
• Molecular Formula: C38H51N5O7
• Molecular Weight: 689.84
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source